Replies to post #12911 on Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

Darter, it won’t come cheap.

[Jesspro]

Dartg, what I meant is that regardless as to who owns the drug, it will be years before they can challenge it, if they even pass P3 with flying colors and stellar data on the follow up studies. And yes you’re right, it may not be in Aurinia’s hand soon.